Keyphrases
Development Impacts
100%
Neonatal Intensive Care Unit
100%
Phthalate Exposure
54%
Preterm Infants
45%
Unit-based
27%
Third Trimester
27%
Neurodevelopment
18%
Stress Exposure
18%
Phthalates
18%
Pubertal Development
18%
Manganese Exposure
18%
Biorepository
18%
Neurobehavioral Development
9%
In Utero Exposure
9%
Cognitive Deficits
9%
Adiposity
9%
Risk Disease
9%
Children Born Preterm
9%
Early-life Exposure
9%
Nutritional Intervention
9%
Chemical Exposure
9%
Neonatal Intensive Care Unit Environment
9%
Direct Measurement
9%
Urinary Biomarkers
9%
Function Performance
9%
Exposure Biomarkers
9%
Tooth Biomarker
9%
Psychological Stress
9%
Hospital Environment
9%
Harmful Compounds
9%
Individual Contribution
9%
Life Stages
9%
Health Outcomes
9%
Cognitive Behavior
9%
Growth Phenotype
9%
Non-chemical
9%
Saliva Biomarker
9%
Multisystem
9%
Neurodevelopmental Phenotypes
9%
Lung Function Growth
9%
Behavioral Performance
9%
Infant Health Risk
9%
Hematologic
9%
Lead Exposure
9%
Term-born Infants
9%
Behavioral Outcomes
9%
Risk Resilience
9%
Pulmonary Function
9%
Resilience Trajectories
9%
Specific Intent
9%
Disease Trajectory
9%
Early childhood
9%
Specific Source
9%
United States
9%
Pharmaceutical Therapy
9%
Performance Development
9%
Neurodevelopmental Outcome
9%
Pediatric Population
9%
Cognitive-motor Performance
9%
Cohort Program
9%
Diverse Populations
9%
Developmental Period
9%
Growth Development
9%
Motor Deficits
9%
Manganese
9%
Hair Biomarker
9%
Essential Trace Metals
9%
Sensitive Population
9%
Clinical Database
9%
Early childhood Development
9%
Lifesaving
9%
Respiratory Therapy
9%
Pb Exposure
9%
Multiple Environmental Exposures
9%
Reproductive Phenotype
9%
Rapid Development
9%
Performance Growth
9%
Adverse Health Outcomes
9%
Pharmacology, Toxicology and Pharmaceutical Science
Phthalic Acid
100%
Biological Marker
25%
Pharmacotherapy
12%
Prematurity
12%
Trace Metal
12%
Health Hazard
12%
Environmental Exposure
12%
Obesity
12%
Diseases
12%